02.01.20|Avior AbouOmer Adam is one of Israel’s most successful musicians, currently topping Spotify Israel’s best-played list
04.06.19|Meir OrbachThe application enables musicians to cash out royalties at any given time once a song has been streamed or played on the radio
31.07.18|Lilach BaumereMusic is a niche player offering subscription-based download of mainly indie, classical and jazz artists and labels
28.05.18|Zohar Shahar LevyIsraeli immunologist Zelig Eshhar, who holds the patent for Kite Pharma’s anti-cancer technology, has been sued by a former student for infringement of patent rights
24.01.18|Omri Milman and Lilach BaumerThe current permit held by Israel-based ICL will expire in 2030. A government draft proposal recommends allowing non-Israeli entities to participate in a future tender
26.12.17|Zohar Shahar LevyIn August, Gilead Science bought anti-cancer treatment company Kite Pharma for $11.9 billion. Two Israeli scientists involved in the early research that led to the company’s breakthrough are now quarreling over patent royalty payments
07.09.17|Sefi KrupskyAfter skirmish with star scientist, the Hebrew University backs down